Carisma Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €16.75M +31.6% -€51.58M -30.4% -308.1% +2.7 pp -€51.00M -25.3% -304.6% +2.3 pp
    €12.73M +51.7% -€74.10M +41.9% -582.3% +0.40 pp -€68.27M +2,654.5% -536.5% -5.1 pp
    €8.39M -63.0% -€52.22M +50.1% -622.6% -4.7 pp -€2.48M -91.8% -29.6% +1.0 pp
    €22.64M +136.2% -€34.79M +43.9% -153.6% +0.99 pp -€30.24M +33.4% -133.6% +1.0 pp
    €9.58M +∞% -€24.18M -73.6% -252.3% -2.5 pp -€22.66M -28.9% -236.5% -2.4 pp
    €0.00 +NaN% -€91.69M +219.1% N/A -€31.89M +63.8% N/A
    €0.00 -100.0% -€28.74M +16.1% N/A -€19.47M +28.5% N/A
    €362.50K -98.6% -€24.76M -1,635.1% -6,830.4% -68 pp -€15.15M -777.5% -4,180.0% -42 pp
    €25.57M +2,928.4% €1.61M -105.7% 6.3% +34 pp €2.24M -107.7% 8.7% +35 pp
    €844.42K -55.9% -€28.53M -3.1% -3,379.0% -18 pp -€29.21M +17.4% -3,458.8% -22 pp
    €1.91M +68.1% -€29.45M +77.8% -1,539.5% -0.83 pp -€24.88M +116.2% -1,300.5% -2.9 pp
    €1.14M +∞% -€16.57M -2.0% -1,456.1% -15 pp -€11.51M -28.9% -1,011.5% -10 pp
    €0.00 +NaN% -€16.91M +52.8% N/A -€16.19M +88.6% N/A
    €0.00 -€11.07M N/A -€8.58M N/A

    Notifications